As of 2:30pm ET
| -1.00 / -2.13%|
The 8 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 55.50, with a high estimate of 94.00 and a low estimate of 39.00. The median estimate represents a +21.62% increase from the last price of 45.64.
The current consensus among 9 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.